Distal Radial and Ulnar Arteries: the Alternative Forearm Access

Parikh, Analkumar; Jia, Kelly; Lall, Sumeet; Shah, Ravi; Gilchrist, Ian C.

doi:10.1007/s11936-020-0801-9

Cited by 9 publications

(9 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study among Japanese population, average diameter was found to be 2.6 ± 0.5 mm by Norimatsu, et al [6]. Similarly, it was reported as 2.41 ± 0.50 mm in left hand and 2.36 ± 0.49 mm in right hand among Korean population as reported by Lee, et al [7,8]. In their series of 637 patients as reported by Babunashvili, et al 5F and 6F sheaths were used in 91% and 9% cases for diagnostic and therapeutic purposes with overall success of 98% [3].…”

Section: Discussionmentioning

confidence: 74%

Untitled

2020

Int J Clin Cardiol

View full text Add to dashboard Cite

Haematoma, dissection, local site granuloma, and persistent radial artery occlusion are few of the complications of conventional transradial access. The distal radial artery located in the "fossa radialis or anatomical snuffbox" on the dor¬sal side of the hand may be an attractive alternative to conventional radial stick. Here, we report a case of a 47-year-old diabetic male who presented with retrosternal chest pain and sweating of 2-hours duration, and diagnosed as acute inferior wall myocardial infarction. Primary percutaneous coronary intervention of culprit right coronary artery was performed through right transradial approach using fossa radialis (dorsal Transradial).

show abstract

Section: Discussionmentioning

confidence: 74%

Untitled

2020

Int J Clin Cardiol

View full text Add to dashboard Cite

show abstract

“…Prior studies have reported that arterial anomalies found from wrist to aorta influence the success of transradial access and are the cause for access crossover from TRA to other access sites 28‐32 . In these cases we must think about alternative wrist access sites that preserve the benefits of radial access 33 …”

Section: Discussionmentioning

confidence: 99%

“…[28][29][30][31][32] In these cases we must think about alternative wrist access sites that preserve the benefits of radial access. 33 When conditions do not allow successful completion of the procedure after cannulation of the radial artery, ipsilateral ulnar access can be safely achieved and conducted without documented ischemic complications of the arm. Bigler et al 34 Also, Ulnar arterial access, like radial arterial access, reduces procedural time in primary PCI, saves the contralateral radial artery for future possible coronary artery bypass grafting and avoids the use of femoral access in patients with high bleeding risk.…”

Section: Discussionmentioning

confidence: 99%

Ipsilateral transulnar artery approach catheterizations after failure of the radial approach—Are two sheaths in the same arm safe?

Zafirovska

Jovkovski

Vasilev

et al. 2021

Cathet Cardio Intervent

View full text Add to dashboard Cite

Aims: To assess the safety and feasibility of ipsilateral transulnar access (TUA) after failure of radial access (TRA), with two sheaths placed in the radial and ulnar arteries (RA and UA) in the same arm.Materials and Methods: All consecutive patients with TUA due to inability to cross from ipsilateral TRA in the period from March 2011 until September 2020 were included in the study. We examined clinical and procedure characteristics, access site bleeding and ischemic complications and failure mode of initial TRA. Patients were assessed by duplex ultrasound post-procedure (at an average of 56 ± 31 months) and followed clinically (functional and pain assessment).Results: In this period, out of 51,866 patients 112 (0.2%) had a transulnar artery approach due to inability to cross from ipsilateral radial approach. Mean age of patients was 65 ± 11 years with 44% females. Cause for crossover to ipsilateral TUA was inability to cross a RA anomaly in 107 (95%) patients, mostly due to the presence of a "360 " RA loop in 88 patients.Type 3 and 4 EASY Score hematoma was present in 3 patients (2.6%). Six (5.3%) of the patients had new ipsilateral radial artery occlusion noted on duplex on follow up. There were no ulnar artery occlusions detected. There were no clinical or ischemic hand complications seen during a median 4.3 years of follow up. Conclusion:Ipsilateral transulnar artery access following failed radial artery access crossing is safe and successful for coronary angiography and intervention with low rates of complications.

show abstract

“…Cisplatin, commonly known as cis-di ammine dichloroplatinum (CDDP), is a highly effective chemotherapy drug [ 109 ]. In diseases such as ovarian and cervical cancer and testicular cancer, it is used alone or in combination regimens [ 110 ].…”

Section: Mode Of Cardiotoxicity Inductionmentioning

confidence: 99%

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

Adhikari

Asdaq²,

Hawaj

et al. 2021

Pharmaceuticals

View full text Add to dashboard Cite

The advancement in therapy has provided a dramatic improvement in the rate of recovery among cancer patients. However, this improved survival is also associated with enhanced risks for cardiovascular manifestations, including hypertension, arrhythmias, and heart failure. The cardiotoxicity induced by chemotherapy is a life-threatening consequence that restricts the use of several chemotherapy drugs in clinical practice. This article addresses the prevalence of cardiotoxicity mediated by commonly used chemotherapeutic and immunotherapeutic agents. The role of susceptible genes and radiation therapy in the occurrence of cardiotoxicity is also reviewed. This review also emphasizes the protective role of antioxidants and future perspectives in anticancer drug-induced cardiotoxicities.

show abstract

Distal Radial and Ulnar Arteries: the Alternative Forearm Access

Cited by 9 publications

References 40 publications

Untitled

Untitled

Ipsilateral transulnar artery approach catheterizations after failure of the radial approach—Are two sheaths in the same arm safe?

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

Contact Info

Product

Resources

About